Paper · 28126011
References128
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 128
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12471242 | Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. | Science | 2002 | https://conductscience.org/library/papers/12471242 | PubMed |
| 2 | 17062558 | Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. | Cancer Res | 2006 | https://conductscience.org/library/papers/17062558 | PubMed |
| 3 | 20363874 | AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. | Mol Endocrinol | 2010 | https://conductscience.org/library/papers/20363874 | PubMed |
| 4 | 14601044 | The IGF-1 receptor in cancer biology. | Int J Cancer | 2003 | https://conductscience.org/library/papers/14601044 | PubMed |
| 5 | 19221486 | Mitotic kinase dynamics of the active form of AMPK (phospho-AMPKalphaThr172) in human cancer cells. | Cell Cycle | 2009 | https://conductscience.org/library/papers/19221486 | PubMed |
| 6 | 17085648 | Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/17085648 | PubMed |
| 7 | 23942093 | Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23942093 | PubMed |
| 8 | 19440038 | Metformin induces unique biological and molecular responses in triple negative breast cancer cells. | Cell Cycle | 2009 | https://conductscience.org/library/papers/19440038 | PubMed |
| 9 | 23663483 | Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23663483 | PubMed |
| 10 | 17355113 | The transcription factor nuclear factor-kappa B and cancer. | Clin Oncol (R Coll Radiol) | 2007 | https://conductscience.org/library/papers/17355113 | PubMed |
| 11 | 21540236 | Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. | Cancer Res | 2011 | https://conductscience.org/library/papers/21540236 | PubMed |
| 12 | 17712357 | AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. | Nat Rev Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17712357 | PubMed |
| 13 | 22643892 | Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. | Nat Commun | 2012 | https://conductscience.org/library/papers/22643892 | PubMed |
| 14 | 25556614 | The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges. | Chin J Cancer | 2015 | https://conductscience.org/library/papers/25556614 | PubMed |
| 15 | 16286006 | mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. | Cell | 2005 | https://conductscience.org/library/papers/16286006 | PubMed |
| 16 | 20234352 | mTOR signaling and drug development in cancer. | Nat Rev Clin Oncol | 2010 | https://conductscience.org/library/papers/20234352 | PubMed |
| 17 | 25421433 | Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro. | Oncol Rep | 2015 | https://conductscience.org/library/papers/25421433 | PubMed |
| 18 | 18212742 | The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. | Oncogene | 2008 | https://conductscience.org/library/papers/18212742 | PubMed |
| 19 | 15314020 | Upstream and downstream of mTOR. | Genes Dev | 2004 | https://conductscience.org/library/papers/15314020 | PubMed |
| 20 | 24644001 | Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24644001 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/28126011/references